Introduction
Celiac disease is a gluten-sensitive enteropathy that occurs in genetically predisposed individuals and responds to the withdrawal of gluten from the diet. Those with dermatitis herpetiformis are considered to have celiac disease. Celiac disease was originally considered a rare malabsorption syndrome of childhood. However, it is now recognized as primarily an adult disease [1] . The development of the disease requires both genetic and environmental factors. The human major histocompatibility molecules DQ2 and DQ8 are essential genetic factors for the development of celiac disease, with the majority of patients carrying DQ2 alleles (DQA1 Ã 05/ DQB1 Ã 02). In the remaining patients, an association with DQ8 (DQA1 Ã 0301/DQB1 Ã 0302) is found. These histocompatibility locus antigen (HLA) genes occur in up to 40% of the Caucasian population. They are considered to confer only 40% of the genetic risk to develop celiac disease; the rest is attributable to non-HLA genes that as yet have to be definitively identified [2] . Overall, 10% of first-degree relatives have celiac disease. This increases to 20% if there are affected sibling pairs in the family [3] .
Environmental factors include a requirement for gluten ingestion. Gluten is the term for the storage proteins of wheat. The alcohol-soluble fraction of gluten, gliadin, is toxic in celiac disease, along with similar proteins in barley (hordeins) and rye (secalins). The role of other environmental factors is evident from the fact that only a small percentage of those ingesting wheat develop celiac disease. Lack of breastfeeding, a large amount of gluten in infant formula and gastrointestinal infections increase the risk of celiac disease in infancy [4] [5] [6] [7] [8] . In addition to protecting against the development of celiac disease, breastfeeding delays the onset and alters the clinical presentation of celiac disease in children [9] [10] [11] . The timing of the introduction of gluten is also important. For most, protection is afforded if gluten introduction occurs during the fourth and sixth months [12 ] .
Epidemiology
Screening studies have revealed that celiac disease is very common, approaching 1% of the population [13] [14] [15] [16] 17 ]. It is recognized across the globe, including Asia [18] , the Middle East [15, 19] , North Africa [20] , and South America [21] . These high prevalence rates are based on serologic screening studies. The bulk of those with celiac disease are currently undiagnosed [13] , although the rate of diagnosis is increasing. Murray et al.
[1] noted a 10-fold increase in the prevalence of celiac disease in 2001 compared to 1950. The disease is considered to be underdiagnosed [22] . As a result, patients have a long duration of symptoms prior to diagnosis [23] . The delay in diagnosis has been attributed to physician delay rather than a delay in patients seeking health care [24] .
Pathogenesis
Those with celiac disease develop an immunological reaction to a fragment of the gliadin molecule, a 33-amino acid peptide, that is resistant to digestion by gastric, pancreatic and duodenal enzymes [25] . The immune reaction in the lamina propria is triggered when gliadin is deamidated by tissue transglutaminase, an enzyme that is present in most tissues. The deamidated gliadin subsequently binds to either DQ2 or DQ8 molecules on antigen-presenting cells. An inflammatory process is then initiated by gliadin-restricted CD4þ T cells [26] , resulting in villous injury. The characteristic intraepithelial lymphocytosis is considered to occur by a different mechanism, one involving the innate immune system [27] . Villous atrophy and intraepithelial lymphocytosis are the histologic hallmarks of the disease.
Diagnosis
While the small-bowel biopsy is the gold standard for the diagnosis of celiac disease, serologic tests are important in the determination of who should be referred for biopsy. The National Institutes of Health Consensus Development Conference on Celiac Disease was convened in June 2004 (the final statement is available online at http:// consensus.nih.gov/PREVIOUSSTATEMENTS.htm# 2004CeliacDisease) [22] . For that conference, Rostom et al. [28 ] reviewed the literature on serologic testing for celiac disease. They recommended that the IgA antitissue transglutaminase or endomysial antibody be used for serologic testing. This is based on a sensitivity and specificity of >90%. In addition they considered the antigliadin antibodies to have too low a sensitivity and specificity to be of value in the diagnosis of celiac disease.
Selective IgA deficiency is 15-fold more common among those with celiac disease than the general population [29] . As a result, those with celiac disease and selective IgA deficiency will lack both IgA endomysial and tissue transglutaminase antibodies. In order to detect celiac disease in this population an IgG tissue transglutaminase antibody should be sought [30] [31] [32] .
Clinical presentation
Celiac disease more resembles a multisystem disorder rather than a primary gastrointestinal disease. Over the last two decades the percentage of patients presenting with diarrhea and malabsorption syndrome has decreased. Instead the majority of patients present in atypical ways, with so-called silent celiac disease in which diarrhea is not prominent. Some patients are truly asymptomatic, detected by screening of at risk groups that include relatives of those with diagnosed celiac disease [16] , type 1 diabetes [33, 34] and Down syndrome [35, 36] . A large screening study from England detected celiac disease in 1%; those with positive celiac serologies considered themselves well, although they had mild anemia and a reduction in bone density [37] . Other patients present as critically ill with a malabsorption syndrome or enteropathy-associated lymphoma. The reason for the tremendously varied presentation is unclear.
For those diagnosed with celiac disease the clinical presentation has changed; more patients with less severe symptoms are being diagnosed [1]. Lo et al. [38] also reviewed 227 patients with biopsy proven celiac disease. Diarrhea was the most common presenting symptom in 62% and the rest were silent. Among the patients in the silent group, 15% had anemia or osteoporosis, 13% were found through screening and 8% were found incidentally at endoscopy. Fewer patients in recent years were presenting with classic symptoms of diarrhea; 43% now compared with 73% before 1993 [38] .
Less dramatic presentations include irritable bowel syndrome. One study revealed that a significant portion (5%) of patients were misdiagnosed with irritable bowel syndrome [39] . In another study, 30% of those diagnosed with celiac disease had a previous diagnosis of irritable bowel syndrome [23] . Clinicians need to be aware that celiac disease does not always present with diarrhea and the various presentations need to be recognized. We will discuss various associated diseases/presentations.
Hematological presentations
Oxentenko et al. [40] found a high incidence of celiac disease -15% -among patients undergoing endoscopy for evaluation of iron-deficiency anemia. The same authors detected celiac disease among 8.7% of 103 patients subjected to routine duodenal biopsy at endoscopy for iron-eficiency anemia [41] . Karnam et al. [42] found a lower incidence of celiac disease -2.8% -in their prospective study of iron-deficient patients who underwent both endoscopy and colonoscopy. They concluded that all patients with iron deficiency should have duodenal biopsies routinely as celiac disease is a common etiology that is treatable [42] . Five percent of another series of iron-deficiency anemic patients had celiac disease; all those with celiac disease had been refractory to oral iron therapy [43] .
Anemia was present in 90% of children with celiac disease in an Indian series [44] . Hematologic manifestations among 22 children with celiac disease included anemia alone in 19 (86.3%), leukopenia in two (9%) patients, and thrombocytopenia in one (4.5%) patient. Twelve patients had an iron-deficiency anemia that coexisted with zinc and vitamin B 12 deficiency [45] . Despite iron supplementation and a gluten-free diet, abnormal hematologic parameters may persist [46] . Vitamin B 12 deficiency was formerly considered rare in celiac disease. However, recent studies reveal that it is common, occurring in 12 and 40% of two recent case series [47, 48] .
Osteoporosis
Reduced bone density is common in patients with celiac disease [49] . A few studies have shown that screening osteoporotic patients with celiac antibodies is beneficial in diagnosing patients with silent celiac disease [50] . The prevalence of celiac disease has been found in 2-7% patients with osteoporosis. Worsening T scores have also been found to correlate with more severe celiac disease [49, 51] . Among 431 patients presenting for bone-density determination, the prevalence of celiac disease was 1.2% for patients with osteopenia, and 2.1% for those with osteoporosis [52] . The yield of screening postmenopausal patients with osteoporosis for celiac disease is low and not considered worthwhile [53] .
Rheumatologic presentations
Among the extraintestinal manifestations of celiac disease, arthritis is common. There have been many case reports of arthritis being the presenting symptom in both adults and children [54] [55] [56] [57] [58] [59] [60] . In one study, systematic examination of patients with celiac disease revealed arthritis to be common; arthritis was present in 26% of 200 celiac patients compared with 7.5% controls. They also found a higher incidence of arthritis among untreated celiac patients. The arthritis was seronegative and oligoarticular, similar to the other enteroarthritides [61] . Bone scintigraphy was carried out to detect early acute inflammatory lesions in 22 adult celiac patients and was positive for sacroiliitis in 14 cases (63.6%) [62] . However, a study in which a cohort of 160 patients with rheumatoid arthritis were screened for celiac disease failed to reveal an increased prevalence of celiac disease [63] . Increased prevalence of celiac disease in juvenile chronic arthritis is controversial [64, 65] .
False-positive tissue transglutaminase antibodies have also been found in patients with arthritis [66] , and IgA tissue transglutaminase antibodies have also been detected in joint fluid of arthritic patients who do not have celiac disease [67] .
Luft et al. [68] tested sera of patients with various rheumatologic disorders including Sjogren's syndrome, rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis for the presence of tissue transglutaminase antibodies and found an increased incidence of celiac disease only among patients with Sjogren's syndrome, of 10%. They did not find an increased frequency of celiac disease among the others [68] . Similarly, Rensch et al. [69] screened patients with systemic lupus erythematosus for antigliadin and antiendomysial antibodies. They found no patients with endomysial antibodies. They did find 23% patients to have positive antigliadin antibodies but no evidence of celiac disease [69] .
Neurologic presentations
Neurologic symptoms as a presenting feature have become increasingly recognized. The most well-documented associations are with peripheral neuropathies, ataxia and epilepsy. The celiac neuropathy is typically a sensory, small-fiber neuropathy. A recent study reported that 23% of patients with celiac disease who were well controlled by diet had peripheral neuropathy compared with a 4% occurrence rate in the control group [70] . At a tertiary-care referral center, celiac neuropathy was found in 2.5% of the patients evaluated for neuropathy [71] . Furthermore, celiac disease was found in 5% of patients with symptoms of neuropathy and normal electrodiagnostic studies, making celiac disease an important diagnostic consideration in the evaluation of 'small-fiber' or idiopathic sensory neuropathies [71] .
Ataxia is one of the more frequent neurologic syndromes associated with celiac disease [72, 73] and is often not suspected due to a lack of gastrointestinal symptoms or signs of malabsorption. The frequency of biopsy-confirmed celiac disease in patients with ataxia of unknown origin ranges from 12 to 15% [73, 74] . One series, however, found no celiac disease-associated antibodies in 32 patients with idiopathic cerebellar ataxia [75] . Celiac disease-associated ataxia often lacks particular clinical features that would distinguish it from other forms of cerebellar ataxia [76] . Severe ataxia in association with celiac disease may respond to intravenous gammaglobulin [77] .
Epilepsy is more recognized as an association with childhood celiac disease than adult celiac disease [78] [79] [80] . Two large studies of adults with celiac disease failed to detect an increased association [81, 82] . The syndrome of occipital calcification, epilepsy in patients with celiac disease, may be reversed with a gluten-free diet [83] [84] [85] .
Blood-test abnormalities
Various blood-test abnormalities have been associated with celiac disease. The more common ones include hyperamylasemia, abnormal liver-function tests, and hypocholesterolemia. Elevated serum amylase, due to macroamylasemia, has been found more commonly among untreated celiac patients than those on a gluten-free diet [86] . In the cases of recurrent pancreatitis, abnormalities of cholecystokinin, impaired secretin release, and papillary stenosis have been proposed [87] .
Abnormal liver tests have been frequently associated with celiac disease. In particular, hypertransaminasemia may be present in up to 40% of patients, both adults and children, and is usually reversible with a gluten-free diet [88] [89] [90] [91] . Celiac disease is detected as the cause of about 10% of cases of cryptogenic hypertransaminasemia [92, 93] . The exact etiology of the liver abnormalities is unknown. Biopsies have shown nonspecific hepatitis as well as steatosis.
It is not a surprising finding that patients with celiac disease often have low cholesterol. Ciacci et al. [94] reviewed 100 patients with hypochromic anemia who did not have diarrhea and found an inverse correlation between cholesterol level and prevalence of celiac disease. All patients with celiac disease were found to have cholesterol values below 156 mg/100 ml. They suggested that among patients with hypochromic anemia, high or high-normal cholesterol could possibly be used to exclude celiac disease [94] . Lower low-density lipoprotein levels have been found in patients with celiac disease and these levels did not necessarily rise after a gluten-free diet [95] .
Oral and facial manifestations
Celiac disease may be manifested in the mouth by the Sjogren's syndrome, [96, 97] , recurrent apthous stomatitis [98] [99] [100] [101] and dental enamel defects [102] [103] [104] [105] . Recently a large forehead has been proposed as a sign of celiac disease [106 ] . This is due to failure of growth of the visceral cranium after weaning, and as a result the middle third of the face is proportionally smaller than the forehead.
Autoimmune diseases
Autoimmune diseases occur in those with celiac disease three to ten times more frequently than in the general population [107] [108] [109] . These diseases (Table 1) include thyroid disease [108, 110, 111] , autoimmune hepatitis and cholangitis [112] [113] [114] , primary biliary cirrhosis [115] , type 1 diabetes mellitus [116] , Sjogren's syndrome [96] , Addison's disease [117] , peripheral neuropathy, psoriasis [118] and cardiomyopathy [119] .
This association with other autoimmune diseases is thought to be secondary to shared HLA alleles, a common immunologic mechanism and the presence of celiac disease itself. Duration of gluten exposure was suggested by Ventura et al. [109] to be linked to the development of autoimmune diseases. However, two recent studies have refuted this [107, 108] . There are reports of improvement of various autoimmune diseases in patients with celiac disease on a gluten-free diet. These include the neuropathy [71] , cardiomyopathy [120] and thyroid disease [108] . However, most associated autoimmune diseases do not improve after a gluten-free diet and diagnosis of celiac disease does not protect from the development of the associated autoimmune diseases [107, 108] .
Conclusion
There are a host of diseases associated with celiac disease (Table 1 ). The varied clinical presentations make the diagnosis challenging. It is therefore important for clinicians of all subspecialities to be aware of the varied symptoms/diseases associated with celiac disease and consider performing celiac serologies.
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